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Haplotype-Sharing Analysis Implicates
Chromosome 7q36 Harboring DPP6
in Familial Idiopathic Ventricular Fibrillation
Marielle Alders,1,10 Tamara T. Koopmann,2,10 Imke Christiaans,1,3 Pieter G. Postema,3
Leander Beekman,2 Michael W.T. Tanck,4 Katja Zeppenfeld,5 Peter Loh,6 Karel T. Koch,3
Sophie Demolombe,7,8,9 Marcel M.A.M. Mannens,1 Connie R. Bezzina,2 and Arthur A.M. Wilde2,3,*
Idiopathic Ventricular Fibrillation (IVF) is deﬁned as spontaneous VF without any known structural or electrical heart disease. A family
history is present in up to 20% of probands with the disorder, suggesting that at least a subset of IVF is hereditary. A genome-wide haplo-
type-sharing analysis was performed for identiﬁcation of the responsible gene in three distantly related families in which multiple
individuals died suddenly or were successfully resuscitated at young age. We identiﬁed a haplotype, on chromosome 7q36, that was
conserved in these three families and was also shared by 7 of 42 independent IVF patients. The shared chromosomal segment harbors
part of the DPP6 gene, which encodes a putative component of the transient outward current in the heart. We demonstrated a
20-fold increase in DPP6 mRNA levels in the myocardium of carriers as compared to controls. Clinical evaluation of 84 risk-haplotype
carriers and 71 noncarriers revealed no ECG or structural parameters indicative of cardiac disease. Penetrance of IVF was high; 50% of
risk-haplotype carriers experienced (aborted) sudden cardiac death before the age of 58 years. We propose DPP6 as a gene for IVF and
increased DPP6 expression as the likely pathogenetic mechanism.Sudden cardiac death (SCD) is the major cause of mortality
in developed countries, and the majority of SCD is caused
by ventricular ﬁbrillation (VF).1–3 In the absence of identi-
ﬁable structural heart disease or known repolarization
abnormalities, it is referred to as idiopathic ventricular
ﬁbrillation (IVF [MIM 603829]). IVF accounts for as many
as 10% of sudden deaths, mainly in the young.2 The recur-
rence of VF in patients with IVF is about 30%, and the only
effective therapy is implantation of an implantable cardi-
overter deﬁbrillator (ICD).2,4 In up to 20% of IVF cases,
a family history of sudden cardiac death or IVF is present,
suggesting that at least a subset of IVF is hereditary.5–7
Because no cardiac abnormalities are observed in IVF
patients, family members that may be at risk cannot be
identiﬁed. Elucidation of underlying genetic defects will
provide more insight into the pathogenesis of the disorder
and, crucially, will allow presymptomatic identiﬁcation of
individuals at risk.
The identiﬁcation of genes involved in IVF is very difﬁ-
cult. Classical linkage analysis is hampered for several
reasons. Unlike that of other monogenic arrhythmia
syndromes, the diagnosis of the disorder cannot be made
on the basis of ECG abnormalities; it can be made only
after the occurrence of (aborted) sudden cardiac death.
Many affected patients die young, thus leaving only small
numbers of patients and material available for analysis.
We set out to identify the culprit gene in three families
(families A, B, and C; Figure 1) in which multiple individ-
uals died suddenly or were successfully resuscitated fromVF at young age. These families originate from the same
area in The Netherlands and are genealogically linked
through multiple lines. This unique situation of three
distantly related IVF families enabled a gene-identiﬁcation
strategy consisting of searching for haplotypes shared in
affected patients. This method identiﬁes chromosomal
segments that are identical by descent (IBD) and are likely
to harbor the disease-causing gene.8,9 Informed consent
was obtained from all individuals studied.
The proband of family A (A-1) visited our cardiogenetics
outpatient clinic because of the SCD of her younger brother
and sister. Her brother died suddenly at age 31, in the early
morning, and postmortem examination did not reveal
a cause of death or cardiac abnormalities. Her sister died
suddenlyatage31, atnight. Sheunderwentcompletecardiac
examination, which was unremarkable, a month before her
death. Cardiac evaluation of the proband A-1 did not reveal
any abnormalities. Six months after this examination, she
suffered VF at age 44 and was successfully resuscitated.
Implantationof anICDfollowed,and ithasneverdischarged
during a follow-up period of 2.5 years. Just a few months
later, her nephew (A-2) was also resuscitated from VF. He
had an ICD implanted, and it discharged appropriately
several times in the next two years after his ﬁrst event.
The proband of family B (B-1) and his children contacted
our cardiogenetics outpatient clinic because of the SCD of
his two sons, who died at age 37 in rest and at age 32 during
sleep, respectively. Postmortem examination revealed no
cause of death, and cardiac abnormalities were absent in1Department of Clinical Genetics, 2Heart Failure Research Center, Department of Experimental Cardiology, 3Department of Cardiology, 4Department of
Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands; 5Department of Cardiology, Leiden University
Medical Center, Leiden, The Netherlands; 6Department of Cardiology, University Medical Center, Utrecht, The Netherlands; 7INSERM, UMR915, L’Institut
du Thorax, Nantes, France; 8CNRS, ERL3147, Nantes, France; 9Universite´ de Nantes, Nantes, France
10These authors contributed equally to this work
*Correspondence: a.a.wilde@amc.uva.nl
DOI 10.1016/j.ajhg.2009.02.009. ª2009 by The American Society of Human Genetics. All rights reserved.
468 The American Journal of Human Genetics 84, 468–476, April 10, 2009
Figure 1. Pedigrees of the Three IVF
Families Used for the Haplotype-Sharing
Analysis
Affected subjects (SCD or resuscitated after
IVF) are shown as filled circles (females) or
squares (males). A slash indicates that the
subject is deceased, and a dot indicates
obligate carrier. The numbers after SCD or
IVF indicate the age of the subject at the
time of the event. Individuals included in
the analysis are indicated with an arrow.
Numbers inside symbols indicate the
number of individuals present of that sex
and status; for example, individual B-1
has four unaffected sisters.both. Although B-1 had no history of arrhythmias, he was
believed to be an obligate carrier of the disease, because
three siblings of his mother also died suddenly at young
age. Cardiac examination ([exercise-]ECG, echocardio-
gram) of the proband and his children revealed no cardiac
abnormalities.The proband of family C (C-1) was admitted to our
hospital after resuscitation from VF at age 33. His cardiac
examination revealed no abnormalities, and an ICD was
implanted. During a follow-up of four years, he had several
appropriate ICD discharges. Two sons of his great grand-
mother had died suddenly at age 30.Figure 2. Mapping of the IVF Locus
(A) Result of the haplotype-sharing analysis. The length of the shared segment in number of SNPs is plotted, and the largest shared haplo-
type, of 301 contiguous SNPs on chromosome 7q36, is indicated by an arrow.
(B) Shared 7q36 chromosomal region, discovered after initial haplotype-sharing analysis and after extended haplotyping in additional
families. The position of the markers and genes (in Mb) is shown, according to the human genome build 36.3. Isoforms 1, 2, and 3 of
DPP6 are also known as isoforms L, S, and K, respectively. Only validated genes are indicated.
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Eight individuals from these three families, indicated by
arrows in Figure 1, were genotyped by genome-wide SNP
analysis with the use of Illumina HumanHap 300 Bead-
Chips. The obtained genotypes were analyzed in Microsoft
Ofﬁce Access. Haplotypes of individuals A-1 and B-1 were
constructed by deﬁning which allele was and which allele
was not transmitted to the offspring. Each haplotype of
A-1 was compared with each haplotype of B-1 and with
the genotypes of patients A-2 and C-1. Shared segments
of >5 contiguous SNPs were plotted (Figure 2A). One large
haplotype of 301 contiguous SNPs on chromosome 7q36
was shared between the three families (Figure 2A), and
this was conﬁrmed by additional genotyping ofmicrosatel-
lite markers within this segment (D7S483, D7S798,
D7S1491, D7S2462, D7S2546, D7S2447, D7S1823). Iden-
tity by descent of four smaller shared segments of >100
SNPs on chromosomes 2, 5, 6, and 12 was excluded by
microsatellite analysis (chr12: D12S88, D12S365; chr2:
D2S2196, D2S1334; chr5: D5S2086, D5S2024; chr6:
D6S2986). Primer sequences of all markers were obtained
from the UniSTS database (see Web Resources). Genomic
DNA was ampliﬁed in the presence of Cy3 dCTP, and frag-
ments were separated on an ABI310 genetic analyzer
(Applied Biosystems). Results were processed with Gene-
mapper software (Applied Biosystems).
The shared haplotype on chromosome 7q36 was actu-
ally 350 SNPs in length when patients B-1, A-1, and C-1
were compared. A recombination occurred when the
haplotype was transmitted to A-2, decreasing the size of
the shared haplotype to 301 SNPs. This haplotype was
bordered by SNPs rs940261 and rs4960710. It was 2.5Mb
in length and contained only four validated genes:
HTR5A [MIM 601305], PAX-IP1 [MIM 608254], DPP6
[MIM 126141], and exons 10–12 of ACTR3B (Figure 2B).
DPP6 encoding dipeptidyl-peptidase 6 was considered
particularly interesting, because it encodes a putative
subunit of potassium-channel complexes. It is predomi-
nantly expressed in brain, where it is associated with Kv4
potassium channels and Kv channel-interacting protein
(KChIP) and underlies the transient subthreshold-
activating, somatodendritic A-type potassium current
(ISA).
10 Studies by Radicke et al.11 showed expression in
heart and are suggestive for a role of DPP6 in cardiac tran-
sient outward current (Ito). Three human isoforms are
known, and they differ at the N terminus (GenBank,
NIH). Direct sequencing of all 28 coding exons in patients
B-1, A-1, and C-1 revealed no mutations in the coding
sequences of DPP6. However, a C/T transition 340 basesupstream of the ATG initiation codon of isoform 2 of the
DPP6 gene (NM_001936) was identiﬁed in all three
patients. It was not present in a control group of 350 Dutch
individuals of European descent (700 alleles) and is speciﬁc
for this particular haplotype.
For examination of the involvement of DPP6 in other
IVF families, 42 probands of additional, independent
families with one or more cases of IVF were screened
for mutations in DPP6. These probands contacted our car-
diogenetics outpatient clinic or were admitted to our
hospital within the last 12 years (1996–2008). IVF was
diagnosed if spontaneous VF occurred in the absence of
electrolyte abnormalities, antiarrhythmic drugs, and any
known cardiac disease as based on routine cardiac investi-
gation, including ECG, exercise-ECG, Holter monitoring,
echocardiography, coronary angiography, and MRI. In
the case of unexplained sudden cardiac death, IVF was
diagnosed in the absence of an identiﬁable cause of death
upon autopsy and/or no cardiac abnormalities in relatives
upon cardiac investigation.
No mutations were detected in the coding region of
DPP6 in these 42 probands. However, the same variant
c.1–340C/T in isoform 2 of DPP6 was identiﬁed in seven
additional families. Additional haplotyping with microsa-
tellite markers revealed that the extended haplotype was
also sharedbetween these families.However, in fourof these
families (families E, G, H, and I; Figure 3), the shared chro-
mosomal region did not span the full length of the original
haplotype. Recombinations must have occurred between
D7S2546 and rs3807218 in families G and E, between the
DPP6 variant c.1–340C/T and D7S2546 in intron 3 of
DPP6 in family H, and between D7S1491 and D7S798 in
families E and I (Figure 3, recombinations indicated by
arrows), reducing the size of the risk haplotype to approxi-
mately 1.5 Mb and, importantly, excluding ACTR3B,
PAXIP1, and HTR5A from the shared region (Figure 2B).
The identiﬁcation of the variant in a substantial propor-
tion of this independent patient group (7/42; 16.6%) and
its absence in 350 controls strongly implies that this haplo-
type contains the disease-causingmutation (p¼1.23107,
Fisher’s exact test). It also implies that alongwith families A,
B, and C, the seven additional families are also descended
from the same ancestor. Genealogical research identiﬁed
links between most families >5 generations ago. The
probands of families H and G, however, were linked more
closely andwere found tobe third cousins.Multipoint para-
metric linkage analysis in the families with multiple
affected individuals (families A, B, GþH, and I) wasFigure 3. Haplotypes in the Ten IVF Families
Haplotype analysis in the ten families (A to J) with the risk haplotype. Probands are labeled 1. Affected subjects (SCD or resuscitated
after IVF) are shown as filled circles (females) or squares (males). A slash indicates that the subject is deceased, and a dot indicates an
obligate carrier. Individuals included in the haplotype-sharing analysis are indicated (B-1, A-1, A-2, C-1), as well as individuals from
whom a cardiac biopsy was used for expression studies (A-2, B-1, H-2, I-1, and J-1). The risk haplotype is colored black. Families E,
G, H, and I carry recombinants, which are indicated with an arrow. The smallest shared segment, based on these recombinations, is indi-
cated with a black bar next to the haplotype. From individuals labeled with an asterisk, DNA was extracted from paraffin-embedded
tissues, and the haplotypes of individuals labeled with a ‘‘þ’’ were inferred from their children.
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Figure 4. Expression Analysis of the DPP6 Gene
(A) Reverse Transcriptase PCR on biopsies of three patients heterozygous for SNP rs3807218. The contribution of the A allele, which is on
the risk haplotype, is increased relative to that of the G allele.
(B) DPP6 mRNA expression in cardiac biopsies from affected individuals, relative to HPRT expression. The quantification of all DPP6
isoforms with primers in exon 6 and 8 was performed on five patient samples, and isoform-specific analysis was performed on two patient
samples. Bars represent standard errors.performed with the use of the easyLinkage software
package12 running the GENEHUNTER v2.1 program,13,14
with the assumption of an autosomal-dominant pattern
of inheritance, a disease-allele frequency of 0.0001, and
a disease penetrance of 0.70. This yielded amaximum addi-
tive LOD score of 5.9.
Despite the lack of mutations in the coding sequence of
DPP6, it remains the only gene in the shared region.
Because mutations outside coding sequences are also
known to affect gene expression, we analyzed expression
of DPP6 in heart biopsies of ﬁve risk-haplotype carriers
(A-2, C-1, H-2, I-1, and J-1; Figure 3). The cardiac biopsies
from these patients were taken from the right interventric-
ular septum (IVS) and were immediately frozen in liquid
nitrogen. Control heart biopsies (n ¼ 13) were taken
from the IVS of hearts of controls (n¼ 3; AcademicMedical
Center Amsterdam) or from explanted nondiseased
human hearts (n ¼ 10, University of Szeged) that were
technically unusable for transplantation and previously
described by Gaborit et al.15 All experimental protocols
were approved by the Ethical Review Committees of the
Academic Medical Center Amsterdam and the Medical
Center of the University of Szeged (No. 51-57/1997 OEJ).
Total RNA was extracted from pulverized heart tissue
with RNA-Bee reagent (Tel-Test) or RNeasy Fibrous Tissue
Mini Kit (QIAGEN) and reverse transcribed with Super-
script II or Superscript III (Invitrogen) and random hexam-
ers, in accordance with the manufacturer’s protocol.
All ﬁve patients were heterozygous for SNP rs3807218 in
exon 7 ofDPP6. Ampliﬁcation ofDPP6 cDNA, with the use
of primers in exons 6 and 8 (present in all isoforms), and
subsequent sequencing showed an imbalance in expres-
sion between the two alleles (Figure 4A). The A allele of
rs3807218, representing the DPP6 risk haplotype (see472 The American Journal of Human Genetics 84, 468–476, April 10Figure 3), was overrepresented relative to the G allele, sug-
gesting increased expression of DPP6 from the risk-haplo-
type allele. To conﬁrm upregulation of DPP6 expression in
these heart biopsies, we performed real-time quantitative
PCR on a Roche LightCycler 480 Real-Time PCR System,
using primers that recognize all DPP6 transcripts and
primers speciﬁc for transcript isoforms 2 and 3 (primer
sequences availableuponrequest). Isoform1wasnot tested,
because no expression of this isoform could be detected in
heart. Values were normalized to hypoxanthine-guanine
phosphoribosyltransferase (HPRT) expression levels, and
measurements were done in triplicate. Data were analyzed
with LinRegPCR software and were corrected for between-
session variation as described previously.16
Average overall DPP6 expression was increased 22-fold
in patients compared to controls (p ¼ 0.01, Mann-Whit-
ney U test) (Figure 4B). Both isoforms 2 and 3 exhibited
increased expression, although increased expression was
more pronounced for isoform 2 (21-fold; p ¼ 0.03,
Mann-Whitney U test) than for isoform 3 (8-fold; p¼ 0.03,
Mann-Whitney U test). Expression of the neighboring
genes ACTRB3 and PAXIP1 was not elevated (data not
shown), suggesting that the upregulation of DPP6 is
speciﬁc rather than due to a general increase of expression
of genes in the region.
For evaluation of the clinical consequences of carrying
the risk haplotype, a total of 155 relatives from the ten
IVF families sharing the identical haplotype on chromo-
some 7q36 were genotyped and risk-haplotype carrier
status was determined. Individuals with otherwise unex-
plained SCD at an age of <50 years were deﬁned as risk-
haplotype carriers when they had ﬁrst-degree relatives
carrying the risk haplotype. Haplotyping in these families
also yielded obligate carriers and an obligate noncarrier of, 2009
the haplotype. Available data on echocardiography,
cardiac MRI, exercise, and baseline ECG were studied, as
well as data on overall mortality and clinical events (resus-
citated from VF or unexplained SCD).
As shown in Table 1, 84 (54%) individuals were identi-
ﬁed as carriers of the risk haplotype. Echocardiographic
and cardiac MRI data (including delayed gadolinium-
enhanced imaging) in, respectively, 23 and 10 high-risk
individuals did not reveal any signiﬁcant or consistent
abnormality. No arrhythmias or signiﬁcant ECG changes
were recorded during exercise testing or Holter moni-
toring. Baseline ECG characteristics of relatives >15 years
of age were not signiﬁcantly different between carriers
and noncarriers of the risk haplotype (Table 1). ECG char-
acteristics of early repolarization17 were found in 3 of 47
risk-haplotype carriers (6%) and in none of the noncarriers
(not signiﬁcant). Ajmaline provocation tests in six high-
risk individuals (three of which had had an event) did
not reveal any sign of Brugada syndrome.
In three individuals who were resuscitated from VF,
mode of spontaneous VF onset was recorded from their
Table 1. Demographic Data, Method of Identification,
Events, and ECG Characteristics in 155 Individuals from Ten
Families with IVF Linked to 7q36: Defined by Haplotype
Risk-Haplotype
Carrier (n ¼ 84)
Risk-Haplotype
Noncarrier (n ¼ 71) p Value
Demographics
Mean age (years) 415 20 325 21 0.01
Age < 50 years of age 58 (69) 54 (76) 0.37
Male (%) 51 (61) 30 (24) 0.02
Method of Identification
DNA haplotype 70 (83) 70 (99)
Obligate* 6 (7) 1 (1)
SCD <50 years of age
and first-degree relative
of carrier*
8 (10) 0 (0)
Events
Death 25 (30) 1 (1)
SCD 19 (76) 0 (0)
Other causes 6 (24) 1 (100)
Resuscitated from VF 11 (13) 0 (0)
Setting of SCD or VF
Sleep 9 (30) -
Rest 17 (57) -
Activity 4 (13) -
ECG Characteristics
PQ (msec) 1615 26 1515 23 0.07
QRS (msec) 915 13 915 12 0.85
QTc (msec) 3955 26 3895 29 0.32
Heart rate (bpm) 685 14 715 17 0.30
Data are mean5 SD or number of patients (%). SCD denotes sudden cardiac
death, asterisk indicates haplotype inferred. ECG characteristics are ob-
tained from 47 haplotype carriers and 43 noncarriers, all >15 years of age.
Differences between high- and low-risk patients were analyzed with
SOLAR.23 p values < 0.05 were considered significant.The AmICD (n ¼ 3) or during an invasive electrophysiological
study (EPS; n ¼ 1). This showed relatively short-coupled
isolated monomorphic extrasystoles, occasionally eliciting
immediate VF (Figure 5). No speciﬁc electrocardiographic
abnormalities (e.g., early repolarization, right precordial
ST elevation, QT prolongation) preceded the VF episode.
A part of spontaneous VF episodes was preceded by several
single monomorphic extrasystoles (such as in Figure 5),
whereas other episodes were initiated from regular sinus
rhythm by one single extrasystole. During EPS, earliest
activation of the extrasystoles was mapped to the right
ventricular lower free anterior wall, compatible with the
morphology on the 12-lead ECG (Figure 5).
Because no abnormalities can be demonstrated using
cardiac diagnostic methods in IVF, the only phenotype of
the disease that can be studied is (aborted) SCD. Median
survival (50%) in risk-haplotype carriers was 58 years
(95% conﬁdence interval 46–69 years; Figure 6). For the
noncarriers, median age of survival could not be calculated
because of the lack of events. Only one noncarrier died (no
SCD); his haplotype could be reconstructed by haplotyp-
ing of his children. All other noncarriers are alive; this
corresponds with survival being necessary for the obtain-
ing of a blood sample for DNA tests. Thirty risk-haplotype
carriers experienced a clinical event: 19, unexplained SCD;
11, resuscitated VF. The youngest individual experiencing
an event was 16 years of age, and the oldest was 77 years
of age. The mean age at event was 36 5 13 years. Males
were overrepresented in this group: they had 23 events,
whereas there were seven events in females.
Unlike other arrhythmia syndromes, such as Brugada
syndrome or Long-QT syndrome, penetrance of IVF
cannot be assessed on the basis of an electrocardiographic
phenotype. In these syndromes, penetrance of ECG char-
acteristics is variable but relatively high compared to the
low penetrance of arrhythmic (lethal) events.18 However,
penetrance of lethal events linked to the chromosome
7q36 risk haplotype is very high; only 50% survival at
58 years. Therefore, any method that allows identiﬁcation
of the subset of the presymptomatic family members at
such a high risk of arrhythmic events is potentially life-
saving. Currently, we use haplotype analysis to identify
relatives at risk and treat accordingly (i.e., ICD implant).
Furthermore, noncarriers of the risk haplotype in
these families can be reassured of the absence of an
increased risk of SCD for themselves and their offspring.
This strategy is, at this time, applicable only to the families
carrying this speciﬁc haplotype, and a reliable classiﬁcation
is made only in cases in which the entire shared haplotype
(between D7S1491 and D7S2546) is present or absent.
Because the causal mutation might be present anywhere
on the shared segment, the risk status of asymptomatic
individuals carrying part of the risk haplotype (as a
consequence of a recombination event) is considered
uncertain.
Currently, we can speculate only on how overexpression
of DPP6 causes IVF. DPP6 is predominantly expressed inerican Journal of Human Genetics 84, 468–476, April 10, 2009 473
brain, where it is a component of the neuronal Kþ current
ISA, but it is also considered an essential component of the
native transientKþ current (ITO) channel complex inhuman
heart.11 Recent studies have shown that the characteristic
kinetics of the native human cardiac ITO are recapitulated
only when Kv4.3 is coexpressed with DPP6 in addition to
the b-subunit KChIP2.11 In particular, DPP6 signiﬁcantly
alters the inactivation kinetics of both Kv4.2 and Kv4.3
Figure 5. A 12-Lead ECG Recording of
a Resuscitated Male
No specific conduction or repolarization
abnormalities are observed. Regular sinus
rhythm is disturbed by spontaneous mono-
morphic extrasystoles (indicated with an
asterisk) with a short coupling interval,
a left bundle branch block morphology,
and a superior axis. The fourth extrasystole
initiates ventricular fibrillation, for which
defibrillation was required (not shown).
Figure 6. Survival
The survival curve of risk-haplotype carriers (black) and noncarriers
(gray), demonstrating a median survival of 58 years for individuals
carrying the high-risk haplotype.
and promotes expression of these
alpha subunits in the cell membrane,
as observed in different heterologous
expression systems.10,11,19
Kv4 subunits appear to assemble in
a 1:1 stoichiometry, meaning that
such channels carry four subunits
each of Kv4 and DPP6 subunits.19
Studies using Kv4-DPP6 fusion pro-
teins enforcing a 1:1 Kv4:DPP6 sub-
unit ratio generated channel com-
plexes with biophysical properties
similar to those of naturally assembled channels. Of rele-
vance to our ﬁnding of increased DPP6 expression in the
patients, coexpression of additional free DPP6 to these
Kv4-DPP6 fusion channels did not affect channel kinetics,
although it is well possible that translocation of Kv alpha
subunits at the cell membrane is promoted, given that
some increase in current amplitude was observed.19
The ITO current, which mediates early (phase 1) cardio-
myocyte repolarization, is distributed heterogeneously
across the ventricular wall, with ITO being more prominent
in epicardium compared to endocardium. DPP6 mRNA
expression, however, appears similar between epicardium
and endocardium,11 and unless the risk haplotype disrupts
this uniform expression, any increase in ITO resulting from
increased DPP6 mRNA in the patients might not neces-
sarily disturb the transmural ITO gradient. In such
a scenario, any increase in ITO amplitude on the cardiac
action-potential morphology would be expected to follow
the background ITO levels in the different myocardial
layers. In epicardium, a deeper phase 1 may ensue with
the appearance of a J-wave on the electrocardiogram,20
a phenomenon that has recently been shown to precede
ventricular arrhythmias in patients with idiopathic VF
(the ‘‘early repolarization syndrome’’).17 An additional
increase in ITO potentially leads to ST-segment elevation.
However, no electrophysiological abnormalities were
observed on the baseline ECG in carriers of the risk haplo-
type and no differences in prevalence of early repolariza-
tion were observed between haplotype carriers and
noncarriers. Importantly, arrhythmic episodes appeared
not to be preceded by any discernable electrocardiographic
abnormality. Any morphological action-potential changes
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that might be present are apparently not sufﬁcient to
inscribe on the ECG and, therefore, are as yet obscuring
the nature of the arrhythmogenic substrate, which in
fact might be very local, in the lower part of the right
ventricular free wall.
The increasedDPP6mRNA levels observed are expected to
be the consequence ofmutations in regulatory sequences of
the gene. The c.1-340C/T variant on the risk haplotype
could underlie this effect. It is in a stretch of bases conserved
among dog, mouse, and rat, and it potentially creates
aGATA-1-likebinding site (TGATAC)onthe reverse strand.21
However, it also remains possible that on the risk haplo-
type, an as yet unidentiﬁed sequence change, which could
even be located tens or hundreds of kilobases away from
the initiation codon, could still underlie the increased
DPP6 expression from the risk haplotype.22
In total, 10 of the 45 families studied carry the risk haplo-
type, suggesting that approximately 20% of cases in our
clinic (which serves as a referral center for a large area in
TheNetherlands) are due to a foundermutation. Additional
studies in cohorts of other ethnicities will have to establish
to which extent DPP6 underlies IVF in other populations.
In conclusion, we provide evidence for a familial compo-
nent in IVF and identiﬁed a risk locus at chromosome
7q36. Our data support a role for DPP6 as the causal
gene, and we propose overexpression of this gene as the
pathogenic mechanism. Identiﬁcation of the genetic basis
of IVF enables presymptomatic genetic diagnosis for
a disorder of which the ﬁrst and only symptom is poten-
tially lethal arrhythmia.
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